Levodopa/carbidopa/entacapone in Parkinson’s disease-Reference-Cited by-同舟云学术

Levodopa/carbidopa/entacapone in Parkinson’s disease

Published:2009-07 Issue:7 Volume:9 Page:929-940
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Seeberger Lauren C,Hauser Robert A

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Clinical Neurology,General Neuroscience

Link

http://www.tandfonline.com/doi/pdf/10.1586/ern.09.64

Reference88 articles.

1. Projected Neurodegenerative Disease Mortality in the United States, 1990–2040

2. EPIDEMIOLOGY OF PARKINSON'S DISEASE

3. Marras C, Tanner C. Epidemiology of Parkinson’s Disease. In:Movement Disorders: Neurologic Principles and Practice (Second Edition). Watts R, Koller W (Eds). McGraw–Hill Medical Publishing, NY, USA 177–195 (2004).

4. Parkinson's Disease

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-Drug Delivery by Anisotropic and Uniform Hybrid Nanostructures: A Comparative Study of the Function and Substrate–Drug Interaction Properties;Pharmaceutics;2023-04-11

2. New approach on sensitive analysis of pimavanserin, levodopa and entacapone based on synergistic effect of graphene nanoplatelets and graphitized carbon nanotubes in functionalized polymer matrix;Electrochimica Acta;2023-01

3. The Impact of Indoles Activating the Aryl Hydrocarbon Receptor on Androgen Receptor Activity in the 22Rv1 Prostate Cancer Cell Line;International Journal of Molecular Sciences;2022-12-28

4. Aryl acrylonitriles synthesis enabled by palladium-catalyzed α-alkenylation of arylacetonitriles with vinyl halides/triflates;Frontiers in Chemistry;2022-12-15

5. Carbidopa suppresses estrogen receptor-positive breast cancer via AhR-mediated proteasomal degradation of ERα;Investigational New Drugs;2022-09-07